Adoptive Transfer of CD8+ T Cell Clones Derived from Central Memory Cells.

Abstract

The present invention provides a method of carrying out adoptive immunotherapy in a primate subject in need thereof by administering the subject a cytotoxic T lymphocytes (CTL) preparation in a treatment-effective amount. The method comprises administering as the CTL preparation a preparation consisting essentially of an in vitro expanded primate CTL population, the CTL population enriched prior to expansion for central memory T lymphocytes, and depleted prior to expansion of effector memory T lymphocytes. In some embodiments, the method may further comprise concurrently administering Interleukin-15 to the subject in an amount effective to increase the proliferation of the central memory T cells in the subject. Pharmaceutical formulations produced by the method, and methods of using the same, are also described.

Bibliographical data

Original languageEnglish
IPCC12N 5/0638
Patent numberUS10,400,215B2
Filing date12.06.14
Country/TerritoryUnited States
Publication statusPublished - 2014
Externally publishedYes